United States: Yearly Stock Market Performance Insight - 1993

Yearly Gainers
634
Yearly Losers
274
Average Return
32.11%
Total Stocks
1,029
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 16 11 9.95% 29
Large Cap 201 78 40.59% 300
Mid Cap 182 71 24.40% 281
Small Cap 60 13 26.38% 91

Yearly Streak Leaders for 1993

Stock Streak Streak Return
13 years โ†‘ 1,471.83%

Coca-Cola continues its impressive multi-year expansion with a 13-year growth streak (0.71 โ†’ 11.16), delivering 1,471.8% cumulative returns. Annual financials validate this performance: 11.1B revenue generating 3.3B net profit (30.0% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

11 years โ†‘ 329.97%

Exxon Mobil demonstrates exceptional long-term growth with a 11-year growth streak (3.67 โ†’ 15.78), delivering 330.0% cumulative returns. Financial performance supports steady gains with 81.1B annual revenue yielding 8.0B profit (Qtr ending Mar 2025). The 9.9% margin provides buffer for continued expansion.

2 years โ†“ -29.13%

Eli Lilly and sees continued yearly losses with a 2-year decline (20.94 โ†’ 14.84), down 29.1% cumulatively. Yet fundamentals remain solid: 12.7B annual revenue generating 2.8B profit (21.7% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

2 years โ†“ -20.20%

Johnson & Johnson navigates difficult years with a 2-year decline (14.06 โ†’ 11.22), down 20.2% cumulatively. Yet fundamentals remain solid: 21.9B annual revenue generating 11.0B profit (50.2% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

13 years โ†‘ 1,134.18%

Illinois Tool Works solidifies its market leadership with a 13-year growth streak (0.79 โ†’ 9.75), delivering 1,134.2% cumulative returns. Annual financials validate this performance: 3.8B revenue generating 700.0M net profit (18.2% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

11 years โ†‘ 2,185.71%

Danaher continues its impressive multi-year expansion with a 11-year growth streak (0.07 โ†’ 1.60), delivering 2,185.7% cumulative returns. Annual financials validate this performance: 5.7B revenue generating 954.0M net profit (16.6% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

4 years โ†“ -39.48%

Humana struggles through multi-year headwinds with a 4-year decline (29.33 โ†’ 17.75), down 39.5% cumulatively. Weak margins on 32.1B annual revenue with only 1.2B profit (3.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -82.07%

Cooper Companies sees continued yearly losses with a 3-year decline (1.45 โ†’ 0.26), down 82.1% cumulatively. Weak margins on 1.0B annual revenue with only 87.7M profit (8.7% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

7 years โ†‘ 534.44%

Federal Signal solidifies its market leadership with a 7-year growth streak (3.31 โ†’ 21.00), delivering 534.4% cumulative returns. Financial performance supports steady gains with 463.8M annual revenue yielding 46.3M profit (Qtr ending Mar 2025). The 10.0% margin provides buffer for continued expansion.

6 years โ†‘ 0.00%

Brinker solidifies its market leadership with a 6-year growth streak (0.00 โ†’ 13.63), delivering 0.0% cumulative returns. Financial performance supports steady gains with 1.4B annual revenue yielding 118.5M profit (Qtr ending Dec 2024). The 8.7% margin provides buffer for continued expansion.

3 years โ†“ -68.87%

Exponent navigates difficult years with a 3-year decline (2.12 โ†’ 0.66), down 68.9% cumulatively. Weak margins on 145.5M annual revenue with only 26.6M profit (18.3% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

2 years โ†“ -82.06%

Meritage Homes sees continued yearly losses with a 2-year decline (2.62 โ†’ 0.47), down 82.1% cumulatively. Annual revenue of 1.4B provides stability, but 122.8M net income (9.0% margin) in Qtr ending Mar 2025 highlights operational challenges requiring strategic shifts.

5 years โ†‘ 301.53%

Lindsay solidifies its market leadership with a 5-year growth streak (2.62 โ†’ 10.52), delivering 301.5% cumulative returns. Annual financials validate this performance: 169.5M revenue generating 19.5M net profit (11.5% margin) demonstrates exceptional profit margins as of Qtr ending May 2025.

4 years โ†‘ 816.00%

Dynex Capital builds shareholder value with a 4-year growth streak (18.75 โ†’ 171.75), delivering 816.0% cumulative returns. Despite 9.0M in annual revenue and - 3.1M loss (-34.0% margin) as of Qtr ending Mar 2025, the market values future potential over current profitability. Long-term investors bet on turnaround.

2 years โ†“ 0.00%

Biolife Solutions sees continued yearly losses with a 2-year decline (0.00 โ†’ 280.00), down 0.0% cumulatively. Financial struggles compound yearly losses: despite 23.9M annual revenue, - 448,000 losses persist (-1.9% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

2 years โ†“ -67.29%

Conmed navigates difficult years with a 2-year decline (9.63 โ†’ 3.15), down 67.3% cumulatively. Weak margins on 321.3M annual revenue with only 6.0M profit (1.9% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

United States Market Yearly Gainers & Losers: 1993

Top United States Stock Gainers (1993)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.70 $1.42 102.86% 64.3M 16.2B
$1.09 $1.80 65.14% 86.7M 21.9B
$11,725.00 $16,325.00 38.94% 13.8K 3.5M
$3.52 $4.74 33.52% 6.4M 1.6B
$17.44 $21.78 25.32% 2.4M 593.7M
$1.40 $1.45 3,525.00% 1.2K 294.4K
$0.50 $9.75 1,850.00% 39.9K 10.1M
$2.22 $8.12 260.89% 405.5K 102.2M
$0.71 $2.29 218.06% 1.5M 367.9M
$4.25 $13.00 205.88% 248.7K 62.7M
$0.09 $0.42 366.67% 470.4K 118.5M
$0.28 $1.06 292.59% 32.9K 8.3M
$2.50 $8.62 256.20% 409.5K 103.2M
$1.09 $3.78 246.79% 178.1K 44.9M
$0.66 $2.20 233.33% 2.5M 635.5M
$1.95 $4.91 153.09% 31.3K 7.9M
$1.62 $3.50 124.36% 754.1K 190.0M
$0.99 $2.00 100.00% 584.3K 147.2M
$3.53 $6.53 86.57% 27.8K 7.0M
$0.27 $0.48 84.62% 143.6K 36.2M

Biggest United States Stock Losers (1993)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.53 $0.26 -50.94% 224.0M 56.5B
$11.29 $8.78 -21.96% 6.8M 1.7B
$5.34 $4.17 -21.76% 19.8M 5.0B
$12.56 $11.22 -11.09% 5.6M 1.4B
$2.66 $2.52 -5.62% 64.4M 16.2B
$18.64 $8.20 -56.01% 542.3K 136.7M
$4.83 $2.58 -45.68% 1.4M 352.9M
$0.47 $0.26 -44.68% 199.0K 50.2M
$2.60 $1.45 -44.02% 11.9M 3.0B
$6.25 $3.56 -40.67% 103.0K 25.9M
$9.12 $4.00 -56.76% 40.0K 10.1M
$0.94 $0.47 -47.19% 54.0K 13.6M
$2.25 $1.29 -45.80% 81.7K 20.6M
$9.38 $5.25 -43.24% 240.5K 60.6M
$5.75 $3.33 -41.68% 28.8K 7.3M
$481.89 $29.21 -94.03% 323 81.4K
$612.50 $280.00 -54.29% 2.5K 621.6K
$8.88 $4.25 -52.14% 94.1K 23.7M
$4.81 $3.15 -34.51% 64.8K 16.3M
$33.50 $25.62 -24.91% 83.1K 21.0M

Most Active United States Stocks During 1993

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$0.53 $0.26 -50.94% 224.0M 56.5B
$1.09 $1.80 65.14% 86.7M 21.9B
$2.66 $2.52 -5.62% 64.4M 16.2B
$0.70 $1.42 102.86% 64.3M 16.2B
$5.34 $4.17 -21.76% 19.8M 5.0B
$2.72 $3.88 42.65% 92.9M 23.4B
$1.06 $2.42 130.48% 18.7M 4.7B
$8.84 $6.19 -29.90% 15.9M 4.0B
$5.73 $5.46 -4.71% 14.4M 3.6B
$0.76 $1.66 118.42% 13.6M 3.4B
$2.35 $1.53 -34.62% 5.9M 1.5B
$4.94 $5.83 19.22% 3.9M 978.7M
$6.38 $7.38 16.04% 3.7M 945.0M
$10.92 $6.75 -37.03% 3.1M 783.6M
$12.52 $7.88 -37.06% 2.7M 670.1M
$1.62 $3.50 124.36% 754.1K 190.0M
$0.99 $2.00 100.00% 584.3K 147.2M
$20.06 $20.69 3.76% 485.1K 122.2M
$28.67 $27.50 -3.78% 448.3K 113.0M
$1.28 $1.55 17.42% 386.4K 97.4M

United States Sector Performance During 1993

Energy

94.08%
52 stocks
Top Performers by Market Cap:
Mega Cap: CVX +25.32%
Large Cap: SU +3,525.00%
Mid Cap: NE +96.91%
Small Cap: RES +27.27%

Consumer Cyclical

63.90%
137 stocks
Top Performers by Market Cap:

Technology

42.71%
116 stocks
Top Performers by Market Cap:

Real Estate

30.57%
53 stocks
Top Performers by Market Cap:
Large Cap: PSA +60.47%
Mid Cap: RHP +37.17%
Small Cap: UMH +52.63%

Basic Materials

30.19%
60 stocks
Top Performers by Market Cap:
Mega Cap: LIN -0.84%
Large Cap: AEM +205.88%
Mid Cap: CDE +84.95%
Small Cap: MTX +33.27%

Industrials

27.85%
192 stocks
Top Performers by Market Cap:
Mega Cap: GE +22.64%
Large Cap: MTZ +113.93%
Small Cap: AMSC +80.00%

Financial Services

21.02%
177 stocks
Top Performers by Market Cap:
Mega Cap: BRK.A +38.94%
Large Cap: SCHW +86.05%
Small Cap: OFG +153.09%

Communication Services

15.43%
27 stocks
Top Performers by Market Cap:
Mega Cap: T +12.17%
Large Cap: CMCSA +87.91%
Mid Cap: USM +59.96%

Utilities

13.69%
48 stocks
Top Performers by Market Cap:
Large Cap: CMS +36.67%
Mid Cap: AES +26.06%
Small Cap: MSEX +24.94%

Consumer Defensive

13.09%
63 stocks
Top Performers by Market Cap:
Mega Cap: KO +6.59%
Large Cap: PRMB +93.19%
Small Cap: IMKTA +62.96%

Healthcare

2.07%
94 stocks
Top Performers by Market Cap:
Mega Cap: UNH +33.52%
Large Cap: IDXX +94.15%
Small Cap: NEOG +84.62%

Data is updated regularly. Yearly performance is calculated based on closing prices.